Skickas . Fri frakt för medlemmar vid köp för minst 249 kr.
The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Miriam Davis, Bruce Altevogt, Megan Reeve
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Miriam Davis, Megan Reeve, Bruce Altevogt
Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Bruce M. Altevogt, Miriam Davis, Diana E. Pankevich
Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Sheena M. Posey Norris, Diana E. Pankevich, Miriam Davis, Bruce M. Altevogt
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Theresa Wizemann, Megan Reeve, Bruce Altevogt
Institute of Medicine, Board on Health Care Services, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Bruce Altevogt, Bradley Eckert, Theresa Wizemann, Megan Reeve
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Bruce Altevogt, Megan Reeve, Theresa Wizemann